Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Fatal outcome of malignant transformation of hidradenitis suppurativa: A case report and literature review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. CENTRAL PRECOCIOUS PUBERTY IN TWO BOYS WITH PRADER-WILLI SYNDROME ON GROWTH HORMONE TREATMENT

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. A rare case of pseudotumor cerebri in adult Lyme disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Hutchinson's sign of ophthalmic zoster

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Increased all-cause mortality in concomitant atopic dermatitis and asthma: A nationwide registry-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Predictors of atopic disease in children of women with asthma

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Safety of the combined use of methotrexate and acitretin in a dermatology hospital setting

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

Vis graf over relationer

Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.

OriginalsprogEngelsk
TidsskriftClinical Case Reports
Vol/bind8
Udgave nummer12
Sider (fra-til)2874-2877
Antal sider4
ISSN2050-0904
DOI
StatusUdgivet - dec. 2020

Bibliografisk note

© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

ID: 61699134